Life Sciences IP

Paul Hastings’ Life Sciences IP practice represents pharmaceutical, biotechnology and medical device innovators in disputes that affect product exclusivity, development programs and commercialization. Our work spans small-molecule therapeutics, biologics, cell and gene therapies, molecular diagnostics and medical devices, including patent disputes involving compounds, formulations, methods of treatment, manufacturing processes and platform technologies.